Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB)

Market Closed
12 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
2. 23
-0.02
-0.8889%
Pre Market
$
2. 52
+0.29 +13.0045%
7.53M Market Cap
- P/E Ratio
- Div Yield
69,480 Volume
-3.91 Eps
$ 2.25
Previous Close
Investors:
Add Transaction
Day Range
2.2 2.36
Year Range
2.2 12
Want to track CLRB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript

Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript

Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript

Seekingalpha | 1 month ago
Cellectar Biosciences (CLRB) Upgraded to Buy: Here's What You Should Know

Cellectar Biosciences (CLRB) Upgraded to Buy: Here's What You Should Know

Cellectar Biosciences (CLRB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 1 month ago
Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call Transcript

Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call Transcript

Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call Transcript

Seekingalpha | 3 months ago
Cellectar Biosciences, Inc. (CLRB) Q3 2025 Earnings Call Transcript

Cellectar Biosciences, Inc. (CLRB) Q3 2025 Earnings Call Transcript

Cellectar Biosciences, Inc. ( CLRB ) Q3 2025 Earnings Call November 13, 2025 8:30 AM EST Company Participants James Caruso - President, CEO & Director Chad Kolean - VP, CFO & Secretary Jarrod Longcor - Chief Operating Officer Conference Call Participants Anne Marie Fields Aydin Huseynov - Ladenburg Thalmann & Co. Inc., Research Division Jeffrey Jones - Oppenheimer & Co. Inc., Research Division Jonathan Aschoff - ROTH Capital Partners, LLC, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025.

Seekingalpha | 7 months ago
Cellectar Biosciences, Inc. (CLRB) Q2 2025 Earnings Call Transcript

Cellectar Biosciences, Inc. (CLRB) Q2 2025 Earnings Call Transcript

Cellectar Biosciences, Inc. (NASDAQ:CLRB ) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Chad J. Kolean - VP, CFO & Secretary James V.

Seekingalpha | 10 months ago
All You Need to Know About Cellectar Biosciences (CLRB) Rating Upgrade to Buy

All You Need to Know About Cellectar Biosciences (CLRB) Rating Upgrade to Buy

Cellectar Biosciences (CLRB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 11 months ago
Cellectar Biosciences Inc. (CLRB) Q1 2025 Earnings Call Transcript

Cellectar Biosciences Inc. (CLRB) Q1 2025 Earnings Call Transcript

Cellectar Biosciences Inc. (NASDAQ:CLRB ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Jim Caruso - President and CEO Chad Kolean - CFO Jarrod Longcor - COO Anne Marie Fields - IR, Managing Director, Precision AQ Conference Call Participants Aydin Huseynov - Ladenburg Thalmann Operator Ladies and gentlemen, thank you for standing by, and welcome. At this time all participants are in listen-only mode.

Seekingalpha | 1 year ago
Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year?

Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year?

Here is how Cellectar Biosciences, Inc. (CLRB) and Cencora (COR) have performed compared to their sector so far this year.

Zacks | 1 year ago
Cellectar Biosciences Inc. (CLRB) Q4 2024 Earnings Call Transcript

Cellectar Biosciences Inc. (CLRB) Q4 2024 Earnings Call Transcript

Cellectar Biosciences Inc. (NASDAQ:CLRB ) Q4 2024 Earnings Conference Call March 13, 2025 8:30 AM ET Company Participants Anne Marie Fields – Managing Director-Precision AQ Jim Caruso – President and Chief Executive Officer Chad Kolean – Chief Financial Officer Jarrod Longcor – Chief Operating Officer Conference Call Participants Jonathan Aschoff – ROTH Operator Ladies and gentlemen, thank you for standing by, and welcome. At this time all participants are in listen-only mode.

Seekingalpha | 1 year ago
Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options

Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options

On Tuesday, Cellectar Biosciences, Inc.  CLRB unveiled a strategic update on its clinical development programs for its proprietary phospholipid ether drug conjugate platform, which targets cancer.

Benzinga | 1 year ago
Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript

Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript

Cellectar Biosciences, Inc. (NASDAQ:CLRB ) Q3 2024 Earnings Conference Call November 18, 2024 8:30 AM ET Company Participants Anne Marie Fields - Managing Director, Precision AQ Jim Caruso - President & CEO Chad Kolean - CFO Andrei Shustov - SVP, Medical Shane Lea - Chief Commercial Officer Jarrod Longcor - COO Conference Call Participants Jeff Jones - Oppenheimer Operator Ladies and gentlemen, thank you for standing by. And welcome at this time, all participants are in listen only mode.

Seekingalpha | 1 year ago
Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131

CLRB announces two presentations featuring its Iopofosine I 131 at the 12th IWWM, in Prague. Jorge Castillo will be the presenter.

Zacks | 1 year ago
Loading...
Load More